Monodispersed strontium containing bioactive glass nanoparticles and MC3T3-E1 cellular response

Abstract Non-porous monodispersed strontium containing bioactive glass (Si2O-CaO-SrO) nanoparticles (Sr- BGNPs), were synthesised using a modified Stöber process. Silica nanoparticles (Si-NPs) with diameters 90 ± 10 nm were produced through hydrolysis and polycondensation reactions of the silicon alkoxide precursor, tetraethyl orthosilicate (TEOS), prior to the incorporation of cations; calcium (Ca) and strontium (Sr), into the silica networks through heat treatment (calcination). Sr was substituted for Ca on a mole basis from non- (0SrBGNPs) to fullsubstitution (100SrBGNPs) in order to increase the amount of network modifiers in the Si-NPs. The different ratios of Si: Ca; 1:1.3 and 1:8.0, presented various elemental compositions (i.e. 77–92 mol% of SiO2). The effect of Si: Ca/Sr ratio on particle size, morphology and dispersitywas evaluated, as well as the in vitro cell viability effect of Sr- BGNPs and their dissolution products on pre-osteoblast cell line, MC3T3-E1. Sr incorporation did not affect particle size or dispersity. For 1:1.3 ratio, SrBGNPs caused no toxic effects on the cells and dissolution products of 75- and 100- SrBGNPs showed great potential to promote MC3T3-E1 activity.

[1]  Julian R. Jones,et al.  Controlling particle size in the Stöber process and incorporation of calcium. , 2016, Journal of colloid and interface science.

[2]  Molly M. Stevens,et al.  Sparse feature selection methods identify unexpected global cellular response to strontium-containing materials , 2015, Proceedings of the National Academy of Sciences.

[3]  Ian M. Reaney,et al.  The osteogenic response of mesenchymal stromal cells to strontium‐substituted bioactive glasses , 2015, Journal of tissue engineering and regenerative medicine.

[4]  Chikara Ohtsuki,et al.  A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants , 2015, Journal of Materials Science: Materials in Medicine.

[5]  W. Stark,et al.  Novel strontium-doped bioactive glass nanoparticles enhance proliferation and osteogenic differentiation of human bone marrow stromal cells , 2013, Journal of Nanoparticle Research.

[6]  Yinghong Zhou,et al.  Strontium-containing mesoporous bioactive glass scaffolds with improved osteogenic/cementogenic differentiation of periodontal ligament cells for periodontal tissue engineering. , 2012, Acta biomaterialia.

[7]  Julian R. Jones.  Sol‐Gel Derived Glasses for Medicine , 2012 .

[8]  Julian R. Jones,et al.  Role of pH and temperature on silica network formation and calcium incorporation into sol–gel derived bioactive glasses , 2012 .

[9]  G. Cuniberti,et al.  Bioactive SrO-SiO2 glass with well-ordered mesopores: characterization, physiochemistry and biological properties. , 2011, Acta biomaterialia.

[10]  Aldo R Boccaccini,et al.  A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. , 2011, Biomaterials.

[11]  Molly M Stevens,et al.  Spherical bioactive glass particles and their interaction with human mesenchymal stem cells in vitro. , 2011, Biomaterials.

[12]  J. Nedelec,et al.  New strontium-based bioactive glasses: physicochemical reactivity and delivering capability of biologically active dissolution products , 2009 .

[13]  Julian R. Jones,et al.  Nanostructure evolution and calcium distribution in sol-gel derived bioactive glass , 2009 .

[14]  E. Brown,et al.  The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis , 2009, Journal of Biological Chemistry.

[15]  J. Nedelec,et al.  Strontium-Delivering Glasses with Enhanced Bioactivity: A New Biomaterial for Antiosteoporotic Applications? , 2008 .

[16]  J. Caverzasio.  Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms. , 2008, Bone.

[17]  Larry L. Hench,et al.  The story of Bioglass® , 2006, Journal of materials science. Materials in medicine.

[18]  P. Marie.  Strontium as therapy for osteoporosis. , 2005, Current opinion in pharmacology.

[19]  Min Chen,et al.  Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. , 2005, Experimental cell research.

[20]  P. Maass.  Towards a theory for the mixed alkali effect in glasses , 1999 .

[21]  L L Hench,et al.  An investigation of bioactive glass powders by sol-gel processing. , 1991, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[22]  D. Day.  Mixed alkali glasses — Their properties and uses , 1976 .

[23]  Larry L. Hench,et al.  Bonding mechanisms at the interface of ceramic prosthetic materials , 1971 .

[24]  J. O. Isard.  The mixed alkali effect in glass , 1969 .

[25]  A. Clark,et al.  Opening paper 2015-Some comments on Bioglass : Four Eras of Discovery and Development , 2015 .

[26]  Julian R. Jones,et al.  Monodispersed Bioactive Glass Submicron Particles and Their Effect on Bone Marrow and Adipose Tissue‐Derived Stem Cells , 2014, Advanced healthcare materials.

[27]  Julian R Jones,et al.  Review of bioactive glass: from Hench to hybrids. , 2013, Acta biomaterialia.

[28]  M. Almukainzi,et al.  Simulated Biological Fluids with Possible Application in Dissolution Testing , 2011 .

[29]  S. Pors Nielsen.  The biological role of strontium. , 2004, Bone.

[30]  W. Stöber,et al.  Controlled growth of monodisperse silica spheres in the micron size range , 1968 .